Skip to main content
Clinical Trials/CTRI/2023/03/050271
CTRI/2023/03/050271Not yet recruitingUnknown

To study the role of suprachoroidal dexamethasone injection in patients with Diabetic Retinopathy

GSVM MEDICAL COLLEGE0 sites52 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
52

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • PATIENTS DIAGNOSED WITH TYPE 2 DIABETES MELLITUS WITH MILD AND MODERATE DIABETIC RETINOPATHY

Exclusion Criteria

  • PATIENTS NOT WILLING TO PARTICIPATE OR READY FOR FOLLOW UP.
  • PATIENTS HAVING SEVERE DIABETIC RETINOPATHY,PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA.
  • PATIENTS WITH UNCONTROLLED DIABETES.
  • PATIENTS WITH ANY OCULAR INFECTION,RAISED INTRAOCULAR PRESSURE,ANY CORNEAL PATHOLOGY,THINNED SCLERA,SCLERITIS,STAPHYLOMA OR ANY OTHER ANTERIOR SEGMENT PATHOLOGY EXCEPT PSEUDOPHAKIC PATIENTS.
  • PATIENTS DIAGNOSED OF ANY OTHER RETINAL OR VITREOUS PATHOLOGIES EXCEPT DIABETIC RETINOPATHY.

Investigators

Sponsor
GSVM MEDICAL COLLEGE

Similar Trials